STOCK TITAN

DocGo Inc. (DCGO) CEO reports 1.11M RSU award and 214K-share tax holdback

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

DocGo Inc.'s Chief Executive Officer and director Lee Bienstock reported equity awards and related tax withholding transactions in the company’s common stock. On December 12, 2025, he received 1,113,495 restricted stock units (RSUs) under DocGo’s 2021 Stock Incentive Plan, which will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025. Each RSU entitles him to receive one share of DocGo common stock upon vesting.

On December 15, 2025, 214,131 RSUs were withheld at a price of $0.91 per share to satisfy his tax liability from RSUs granted on December 12, 2023 and December 12, 2024. After these transactions, Bienstock beneficially owns 2,836,281 shares of DocGo common stock directly, including previously granted RSUs scheduled to vest on various dates between March 28, 2026 and December 12, 2028 under the plan.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bienstock Lee

(Last) (First) (Middle)
C/O DOCGO INC.
685 THIRD AVENUE, 9TH FLOOR

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DocGo Inc. [ DCGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/12/2025 A 1,113,495(1) A $0 3,050,412(2) D
Common Stock 12/15/2025 F 214,131(3) D $0.91 2,836,281(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). The RSUs will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
2. In addition to the RSUs granted on December 12, 2025, this amount reflects: (i) 402,745 RSUs granted pursuant to the Plan that will vest in three equal annual installments on each of December 12, 2026, December 12, 2027 and December 12, 2028; (ii) 36,714 RSUs granted pursuant to the Plan that will vest on March 28, 2026; (iii) 60,975 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of May 12, 2026 and May 12, 2027; and (iv) 570,402 RSUs granted pursuant to the Plan that will vest in two equal annual installments on each of December 12, 2026 and December 12, 2027. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
3. The reported transaction reflects the withholding of RSUs in satisfaction of the Reporting Person's tax liability. The RSUs were granted to the Reporting Person on December 12, 2023 and December 12, 2024 pursuant to the Plan.
Remarks:
/s/ Jerilyn Laskie, as Attorney-in-Fact for Lee Bienstock 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider reporting this Form 4 for DocGo (DCGO)?

The reporting person is Lee Bienstock, who serves as a director and the Chief Executive Officer of DocGo Inc..

What equity award did DocGo (DCGO) CEO Lee Bienstock report?

On December 12, 2025, Lee Bienstock reported receiving 1,113,495 restricted stock units (RSUs) under DocGo’s 2021 Stock Incentive Plan. The RSUs vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, and each RSU represents the right to receive one share of DocGo common stock upon vesting.

How many DocGo (DCGO) shares does Lee Bienstock own after these transactions?

Following the reported transactions, Lee Bienstock beneficially owns 2,836,281 shares of DocGo common stock, held directly. This figure includes RSUs granted under the 2021 Stock Incentive Plan that are scheduled to vest on future dates.

Why were 214,131 DocGo (DCGO) shares withheld at $0.91?

The Form 4 shows a transaction on December 15, 2025 in which 214,131 RSUs were disposed of at a price of $0.91 per share. The explanation states that this reflects the withholding of RSUs to satisfy Lee Bienstock’s tax liability from RSUs granted to him on December 12, 2023 and December 12, 2024 under the 2021 Stock Incentive Plan.

When will the new DocGo (DCGO) RSUs granted on December 12, 2025 vest?

The 1,113,495 RSUs granted on December 12, 2025 will vest in four equal annual installments on each of the first four anniversaries of December 12, 2025, subject to the terms of DocGo’s 2021 Stock Incentive Plan.

What other RSU grants to the DocGo (DCGO) CEO are included in his holdings?

In addition to the new RSUs granted on December 12, 2025, his reported holdings include RSUs under the 2021 Stock Incentive Plan that are scheduled to vest as follows: 402,745 RSUs in three equal annual installments on December 12, 2026, 2027 and 2028; 36,714 RSUs vesting on March 28, 2026; 60,975 RSUs vesting in two equal annual installments on May 12, 2026 and May 12, 2027; and 570,402 RSUs vesting in two equal annual installments on December 12, 2026 and December 12, 2027.

DOCGO INC

NASDAQ:DCGO

DCGO Rankings

DCGO Latest News

DCGO Latest SEC Filings

DCGO Stock Data

86.09M
88.43M
7.31%
52.38%
4.13%
Medical Care Facilities
Services-health Services
Link
United States
NEW YORK